Skip to main content
Premium Trial:

Request an Annual Quote

BioRad Completes $200M Exchange Offer for Senior Notes

NEW YORK, June 1 (GenomeWeb News) - Bio-Rad Laboratories has completed an exchange offer that allowed holders of $200 million worth of senior subordinated notes acquired through a private sale last year to obtain amended, publicly registered notes as of yesterday, the company said.

 

According to Ron Hutton, the treasurer of the Hercules, Calif.-based life sciences firm, Bio-Rad offered the note exchange at the beginning of May to investors that had purchased the 6.125-percent notes, due 2014, in December 2004. The amended notes can be publicly traded, as opposed to the old privately issued notes, Hutton said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.